Olivier Parant

Olivier Parant

Auto-generated profile, based on publicly available information

Olivier Parant

Service de gynécologie-obstétrique, hôpital Paule-de-Viguier, CHU Purpan, 330, avenue de Grande-Bretagne, 31059 Toulouse cedex 9, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Redox Biology
Verified
Journal Article
Open access
PGPaul Guerby
Paul Guerby
OTOriane Tasta
Oriane Tasta
ASAudrey Swiader
Audrey Swiader
FPFrédéric Pont
Frédéric Pont
EBEmmanuel Bujold
Emmanuel Bujold
Anne Negre-SalvayreAnne Negre-Salvayre
Anne Negre-Salvayre
Preeclampsia (PE) is a multifactorial pregnancy disease, characterized by new-onset gestational hypertension with (or without) proteinuria or end-organ failure, exclusively observed in humans. It is a leading cause of maternal morbidity affecting 3-7% of pregnant women worldwide. PE pathophysiology could result from abnormal placentation due to a defective trophoblastic invasion and an impaired remodeling of uterine spiral arteries, leading to a poor adaptation of utero-placental circulation. This would be associated with hypoxia/reoxygenation phenomena, oxygen gradient fluctuations, altered antioxidant capacity, oxidative stress, and reduced nitric oxide (NO) bioavailability. This results in part from the reaction of NO with the radical anion superoxide (O2•-), which produces peroxynitrite ONOO-, a powerful pro-oxidant and inflammatory agent. Another mechanism is the progressive inhibition of the placental endothelial nitric oxide synthase (eNOS) by oxidative stress, which results in eNOS uncoupling via several events such as a depletion of the eNOS substrate L-arginine due to increased arginase activity, an oxidation of the eNOS cofactor tetrahydrobiopterin (BH4), or eNOS post-translational modifications (for instance by S-glutathionylation). The uncoupling of eNOS triggers a switch of its activity from a NO-producing enzyme to a NADPH oxidase-like system generating O2•-, thereby potentiating ROS production and oxidative stress. Moreover, in PE placentas, eNOS could be post-translationally modified by lipid peroxidation-derived aldehydes such as 4-oxononenal (ONE) a highly bioreactive agent, able to inhibit eNOS activity and NO production. This review summarizes the dysfunction of placental eNOS evoked by oxidative stress and lipid peroxidation products, and the potential consequences on PE pathogenesis.

11 February 2021 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
CDCaroline Diguisto
Caroline Diguisto
AGAmélie Le Gouge
Amélie Le Gouge
CAChloé Arthuis
Chloé Arthuis
NWNorbert Winer
Norbert Winer
OPOlivier Parant
Olivier Parant
F(For The Groupe de Recherche En Obstétrique Et Gynécologie (Grog)
For The Groupe de Recherche En Obstétrique Et Gynécologie (Grog)
Background: Prolonged pregnancies are a frequent indication for induction of labour. When the cervix is unfavourable, cervical ripening before oxytocin administration is recommended to increase the likelihood of vaginal delivery, but no particular method is currently recommended for cervical ripening of prolonged pregnancies. This trial evaluates whether the use of mechanical cervical ripening with a silicone double balloon catheter for induction of labour in prolonged pregnancies reduces the cesarean section rate for nonreassuring fetal status compared with pharmacological cervical ripening by a vaginal pessary for the slow release of dinoprostone (prostaglandin E2). Methods and findings: This is a multicentre, superiority, open-label, parallel-group, randomised controlled trial conducted in 15 French maternity units. Women with singleton pregnancies, a vertex presentation, ≥41+0 and ≤42+0 weeks’ gestation, a Bishop score <6, intact membranes, and no history of cesarean delivery for whom induction of labour was decided were randomised to either mechanical cervical ripening with a Cook Cervical Ripening Balloon or pharmacological cervical ripening by a Propess vaginal pessary serving as a prostaglandin E2 slow-release system. The primary outcome was the rate of cesarean for nonreassuring fetal status, with an independent endpoint adjudication committee determining whether the fetal heart rate was nonreassuring. Secondary outcomes included delivery (time from cervical ripening to delivery, number of patients requiring analgesics), maternal and neonatal outcomes. Between January 2017 and December 2018, 1,220 women were randomised in a 1:1 ratio, 610 allocated to a silicone double balloon catheter, and 610 to the Propess vaginal pessary for the slow release of dinoprostone. The mean age of women was 31 years old, and 80% of them were of white ethnicity. The cesarean rates for nonreassuring fetal status were 5.8% (35/607) in the mechanical ripening group and 5.3% (32/609) in the pharmacological ripening group (proportion difference: 0.5%; 95% confidence interval (CI) −2.1% to 3.1%, p = 0.70). Time from cervical ripening to delivery was shorter in the pharmacological ripening group (23 hours versus 32 hours, median difference 6.5 95% CI 5.0 to 7.9, p < 0.001), and fewer women required analgesics in the mechanical ripening group (27.5% versus 35.4%, difference in proportion −7.9%, 95% CI −13.2% to −2.7%, p = 0.003). There were no statistically significant differences between the 2 groups for other delivery, maternal, and neonatal outcomes. A limitation was a low observed rate of cesarean section. Conclusions: In this study, we observed no difference in the rates of cesarean deliveries for nonreassuring fetal status between mechanical ripening with a silicone double balloon catheter and pharmacological cervical ripening with a pessary for the slow release of dinoprostone. Trial registration: ClinicalTrials.gov NCT02907060.

1 February 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
OTOriane Tasta
Oriane Tasta
ASAudrey Swiader
Audrey Swiader
MGMarie-Hélène Grazide
Marie-Hélène Grazide
MRMyriam Rouahi
Myriam Rouahi
OPOlivier Parant
Olivier Parant
Anne Negre-SalvayreAnne Negre-Salvayre
Anne Negre-Salvayre

1 March 2011 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
MAMickaël Allouche
Mickaël Allouche
CHCyril Huissoud
Cyril Huissoud
BGBéatrice Guyard-Boileau
Béatrice Guyard-Boileau
RRRoman Rouzier
Roman Rouzier
OPOlivier Parant
Olivier Parant

8 February 2019 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
JBJérémy Brunello
Jérémy Brunello
PGPaul Guerby
Paul Guerby
CCChloé Cartoux
Chloé Cartoux
AYAlexandre Yazigi
Alexandre Yazigi
MBMartin Baujat
Martin Baujat
FVFabien Vidal
Fabien Vidal

1 January 2011 in EMC - Obstétrique
Verified
Journal Article
Closed access
OPO. Parant
O. Parant
CSC. Simon-Toulza
C. Simon-Toulza
AFA. Fournié
A. Fournié